Hurley Ariel — SEC Form 4 filings
SEC reporting owner CIK 1769740. 11 Form 4 filings on record with FilingPulse; latest filed 2025-07-21.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-03-06 to 2025-07-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 19 legs across 9 filings — 25,051 shares, $2,441,567 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 31.
- Largest priced transaction: sale of 3,582 shares @ $107.22 ($384,062) in Blueprint Medicines Corp, filed 2024-05-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Blueprint Medicines Corp (BPMC) | Principal Accounting Officer | 11 | — | 19 legs · 25,051 sh · $2,441,567 | 31 |
Form 4 filings — Hurley Ariel
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-07-21 | 4 | Blueprint Medicines Corp (BPMC) | Grant/award (A): 2,460 · Disposition to issuer (D): 16,146 · Code (U): 3,378 · Disposition to issuer (D): 2,250 (derivative) · Disposition to issuer (D): 12,000 (derivative) · Disposition to issuer (D): 11,399 (derivative) · +6 more | EDGAR |
| 2025-05-07 | 4 | Blueprint Medicines Corp (BPMC) | Option exercise (M): 2,752 @ $54.13 · Sale (S): 1,252 @ $102.51 · Sale (S): 1,400 @ $103.57 · Sale (S): 100 @ $104.78 · Option exercise (M): 2,752 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | Blueprint Medicines Corp (BPMC) | Sale (S): 1,326 @ $88.80 | EDGAR |
| 2025-03-04 | 4 | Blueprint Medicines Corp (BPMC) | Grant/award (A): 6,506 @ $0 · Sale (S): 775 @ $89.63 · Sale (S): 238 @ $90.92 · Sale (S): 631 @ $92 · Sale (S): 484 @ $93.42 · Sale (S): 1,075 @ $95.16 · +1 more | EDGAR |
| 2025-01-15 | 4 | Blueprint Medicines Corp (BPMC) | Option exercise (M): 2,250 @ $36.05 · Sale (S): 2,250 @ $100 · Option exercise (M): 2,250 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | Blueprint Medicines Corp (BPMC) | Option exercise (M): 1,600 @ $15.01 · Sale (S): 1,200 @ $92.88 · Sale (S): 619 @ $93.99 · Option exercise (M): 1,600 (derivative) @ $15.01 | EDGAR |
| 2024-05-17 | 4 | Blueprint Medicines Corp (BPMC) | Option exercise (M): 4,500 @ $36.05 · Option exercise (M): 1,356 @ $43.15 · Sale (S): 3,582 @ $107.22 · Sale (S): 2,274 @ $106.56 · Option exercise (M): 4,500 (derivative) @ $0 · Option exercise (M): 1,356 (derivative) @ $0 | EDGAR |
| 2024-05-06 | 4 | Blueprint Medicines Corp (BPMC) | Option exercise (M): 1,834 @ $54.13 · Sale (S): 1,834 @ $103.88 · Option exercise (M): 1,843 (derivative) @ $0 | EDGAR |
| 2024-03-19 | 4 | Blueprint Medicines Corp (BPMC) | Option exercise (M): 800 @ $15.01 · Sale (S): 800 @ $87.28 · Option exercise (M): 800 @ $15.01 · Sale (S): 800 @ $90 · Sale (S): 2,949 @ $87.28 · Option exercise (M): 1,600 (derivative) @ $0 | EDGAR |
| 2024-03-11 | 4 | Blueprint Medicines Corp (BPMC) | Sale (S): 1,462 @ $90.69 | EDGAR |
| 2024-03-06 | 4 | Blueprint Medicines Corp (BPMC) | Grant/award (A): 5,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1769740 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →